DIOSynVax

Biotechnology Research • Cambridge, England, United Kingdom • 21-50 Employees

Company overview

Headquarters	Cambridge, Cambridgeshire CB3 0ES, GB
Websites	diosvax.com diosynvax.com
NAICS	541714
Founded	2017
Employees	21-50
Socials

Key Contacts at DIOSynVax

Dr Terry Parlett

Director

Simon Frost

Co-Founder And Principal Data Scientist

Rory Shaw

Non Executive Director

Rebecca Kinsley

Chief Executive Officer

DIOSynVax Email Formats

DIOSynVax uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@diosvax.com), used 52.6% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@diosvax.com	52.6%
{first initial}	j@diosvax.com	21.1%
{first name}.{last name}	john.doe@diosvax.com	21.1%
{first initial}.{first3}{last name}	j.{first3}doe@diosvax.com	5.3%

About DIOSynVax

DIOSVax is a biotech startup working to revolutionise the way humanity protects itself from infectious disease and emerging pathogens. The company is named after its core technology, DIOSynVax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines), a new system that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.

DIOSynVax revenue & valuation

Annual revenue	$1,882,210
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,100,000
Total funding	$42,000,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager

Entry

C-Suite

Employees by Department

DIOSynVax has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore DIOSynVax's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-04-08	9	$42,000,000

Funding Insights

$42,000,000

Total funding amount

$42,000,000

Most recent funding amount

Number of funding rounds

DIOSynVax Tech Stack

Discover the technologies and tools that power DIOSynVax's digital infrastructure, from frameworks to analytics platforms.

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

Wix

Blogs

Apple iCloud Mail

Webmail

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

Envoy

Reverse proxies

Frequently asked questions

DIOSynVax is located in Cambridge, England, GB.

DIOSynVax was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

DIOSynVax has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

DIOSynVax has raised a total of $42,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.